Previous 10 |
CERo is an innovative immunotherapy company seeking to advance the next generation of engineered T cell therapeutics that employ phagocytic mechanisms. Its lead product candidate is expected to enter clinical trials in 2024. Anticipated cash resources will fund the advancement of CERo...
News, Short Squeeze, Breakout and More Instantly...
Phoenix Biotech Acquisition Corp. Company Name:
PBAX Stock Symbol:
NASDAQ Market:
Phoenix Biotech Acquisition Corp. (NASDAQ:PBAX) (“PBAX”) and CERo Therapeutics, Inc., an innovative immunotherapy company seeking to advance the next generation of engineered T cell therapeutics that employ phagocytic mechanisms (“CERo”) today announced that their prev...
Shares of Big Lots, Inc. (NYSE: BIG) fell sharply during Monday’s session after the company reported preliminary fourth-quarter results. Als...
A look at the top 10 most actives in the United States NanoString Technologies Inc. (NSTG) rose 118.4% to $0.1162 on volume of 394,556,402 shares U Power Limited (UCAR) rose 45.5% to $0.0959 on volume of 274,384,293 shares Palantir Technologies Inc. Class A (PLTR) rose 3.9% to $24.51 on v...